Anonymous
Guest
Anonymous
Guest
Old Nexium rep here. A few points:
1. Nexium isn't really any better than the others. Sure ph > 4 longer, better healing, blah blah blah. None of it really matters to patients or docs.
2. If DTC is the reason Nexium is number one why doesn't every PPI company do DTC?
3. AZ reps need to realize that not every company NEEDS 40% share of the PPI market. A few market share points in a 6 billion dollar market pays the bills for a small company like Santarus. Don't be an idiot and think you're crushing with a 48 share. A 5 share for a small pharma company is just as good.
4. Santarus...a capsule version of Zegerid? Congrats, you just reinvented Prilosec.
1. Nexium isn't really any better than the others. Sure ph > 4 longer, better healing, blah blah blah. None of it really matters to patients or docs.
2. If DTC is the reason Nexium is number one why doesn't every PPI company do DTC?
3. AZ reps need to realize that not every company NEEDS 40% share of the PPI market. A few market share points in a 6 billion dollar market pays the bills for a small company like Santarus. Don't be an idiot and think you're crushing with a 48 share. A 5 share for a small pharma company is just as good.
4. Santarus...a capsule version of Zegerid? Congrats, you just reinvented Prilosec.